Prior Investment

Stereotaxis

NASDAQ: STXS
Stereotaxis (NASDAQ: STXS) designs, manufactures, and markets an advanced cardiology instrument control system for the interventional treatment of coronary artery disease and arrhythmias. The system allows physicians to more effectively navigate catheters and stent delivery devices using computer-controlled, externally applied magnetic fields that precisely govern the motion of the working tip of the device. www.stereotaxis.com